Error message
Notice: Undefined index: content in _drupal_default_html_head() (line 345 of /var/www/vhosts/rovi.es/httpdocs/includes/common.inc).
|
Date |
Title |
Description |
PDF |
|
15 Mar 2022 |
On significant placements in financial instruments |
Bestinver announces details of an accelerated book building process of approximately 5% of the share capital of Laboratorios Farmacéuticos Rovi, S.A.
|
Download |
|
14 Mar 2022 |
On significant placements in financial instruments |
Bestinver announces the beginning of an accelerated book building process approximately 5% of the share capital of Laboratorios Farmacéuticos Rovi, S.A.
|
Download |
|
23 Feb 2022 |
About corporate governance |
The Company informs about the agreements adopted by the Board of Directors
|
Download |
|
23 Feb 2022 |
On business and financial situation |
The Company releases the press release related to the full year 2021 financial results
|
Download |
|
23 Feb 2022 |
On business and financial situation |
The Company releases the full year 2021 financial results presentation
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
28 Jul 2021 |
On business and financial situation |
The company releases the press release related to first half 2021 financial results
|
Download |
|
28 Jul 2021 |
On business and financial situation |
ROVI releases the first half 2021 results presentation
|
Download |
|
05 Jul 2021 |
Liquidity contracts and specialists |
Liquidity contract: transactions conducted in the second quarter of 2021
|
Download |
|
02 Jul 2021 |
Other relevant information |
The Company informs about the dividends payment
|
Download |
|
02 Jul 2021 |
Other relevant information |
The Company informs about the dividends payment
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
05 Oct 2017 |
Contratos de liquidez y contrapartida |
Liquidity contract: modification of transactions conducted from 11 July to 30 September 2017.
|
Download |
|
03 Oct 2017 |
Contratos de liquidez y contrapartida |
Liquidity contract: transactions conducted from 11 July to 30 September 2017
|
Download |
|
07 Sep 2017 |
Otros sobre negocio y situación financiera |
The Company informs that commences the enoxaparin biosimilar marketing in Germany
|
Download |
|
26 Jul 2017 |
Información sobre resultados |
ROVI releases the presentation related to the 2017 first half results
|
Download |
|
26 Jul 2017 |
Información sobre resultados |
ROVI releases the presentation related to the 2017 first half results
|
Download |
Pages
